Global Locations

Empagliflozin Intermediate 1



Chemical Properties of 'Empagliflozin Intermediate 1'

CAT No. :

CS-O-14892
CAS Registry No. : 360568-68-8
Category : Intermediates
Molecular Weight: 311.56
Molecular Formula : C13H8BrClO2



OTHER INFORMATION of 'Empagliflozin Intermediate 1'
Purity : >98%
Therapeutic : Anti-Diabetic
Purity : >98%
Therapeutic : Anti-Diabetic
Applicationnotes :An intermediate of Empagliflozin.
Synonym :(5-bromo-2-chlorophenyl)(4-hydroxyphenyl)methanone;(5-bromo-2-chlorophenyl)(4-hydroxyphenyl)methanone.
References :"Thomas; L,; et al,: Diabetes, Obesity, Metabol, 14; 94 (2012); Grempler; R,; et al,: Diabetes, Obesity, Metabol,; 14; 83 (2012),"
Smileys :O=C(C1=CC=C(O)C=C1)C(C=C(Br)C=C2)=C2Cl
Custom Duty : Applicable
Port of Loading : Canada
Expected Dispatch : 15-Aug-2022
Taxes : Not Applicable
Refund Policy : 30-days money back
Custom Duty : Applicable
Port of Loading : Canada
Expected Dispatch : 15-Aug-2022
Taxes : Not Applicable
Refund Policy : 30-days money back


More information about Empagliflozin


Empagliflozin, sold under the brand name Jardiance among others, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes, used to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, used to reduce the risk of death and hospitalization in people with heart failure and low ejection fraction, and used to reduce the risk of cardiovascular death and hospitalization for heart failure in adults. It can be prescribed instead of metformin and has benefits over sulfonylureas. It may be used together with other medications such as metformin or insulin. It is not recommended for type 1 diabetes. It is taken by mouth.

Common side effects include urinary tract infections, fungal infections of the groin, and joint pains. Rarer but more serious side effects include a skin infection of the groin called Fournier's gangrene and a form of diabetic ketoacidosis with normal blood sugar levels. Use in pregnancy and breastfeeding is not recommended. Use is not recommended in those with significant kidney disease, though it may help slow the progression of mild kidney problems. Empagliflozin is an inhibitor of the sodium glucose co-transporter-2 (SGLT-2), and works by increasing sugar lost in the urine.

Empagliflozin was approved for medical use in the United States and in the European Union in 2014. It is on the World Health Organization's List of Essential Medicines. In 2019, it was the 146th most commonly prescribed medication in the United States, with more than 4\u00a0million prescriptions.





This page contains information about Empagliflozin Intermediate 1 , Empagliflozin Intermediate 1 cas, Empagliflozin Intermediate 1 synthesis, Empagliflozin Intermediate 1 suppliers

What is Empagliflozin Intermediate 1 ?
Empagliflozin Intermediate 1 falls under Intermediates of Empagliflozin.An intermediate of Empagliflozin.
What is the CAS Number of Empagliflozin Intermediate 1?
The CAS Number of Empagliflozin Intermediate 1 is 360568-68-8
Who are the suppliers of Empagliflozin Intermediate 1?
CLEARSYNTH is a worldwide supplier of Empagliflozin Intermediate 1

Related compounds of Empagliflozin Intermediate 1

Looking for a discounted price or need more info for 'Empagliflozin Intermediate 1 (CS-O-14892)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.

Looking for a discounted price or need more info for 'Empagliflozin Intermediate 1 (CS-O-14892)' ?

If you are looking for Bulk purchase, Discounted Price, etc. please share your email and the exact quantity you are looking for, our team will respond to you within 30 mins with all the required information.